Department of Urology, Yonsei University College of Medicine, Seoul, Republic of Korea.
School of Mechanical Engineering, Yonsei University, Seoul, Republic of Korea.
J Urol. 2018 Jun;199(6):1622-1630. doi: 10.1016/j.juro.2017.09.173. Epub 2018 Feb 2.
Excessive bulking force during primary access of the ureteral access sheath may induce ureteral injury. We investigated the efficacy of preoperative α-blockade to reduce ureteral access sheath insertion force and determine the upper limit required to avoid ureteral injury.
In this randomized controlled trial 135 patients from a single institution who had ureteropelvic junction or renal pelvis stones and were scheduled to undergo retrograde intrarenal surgery were prospectively enrolled from December 2015 to January 2017. Of the patients 41 and 42 were randomly assigned to the control and experimental groups, respectively. The experimental group received α-blockade preoperatively. The 21 patients who were pre-stented were assessed separately. We developed a homemade device to measure maximal ureteral access sheath insertion force.
Our ureteral access sheath insertion force measurement device showed excellent reproducibility. Higher insertion velocity resulted in greater maximal sheath insertion force. Maximal insertion force in the α-blockade group was significantly lower than in the control group at the ureterovesical junction (p = 0.008) and the proximal ureter (p = 0.036). Maximal insertion force in the α-blockade group was comparable to that in pre-stented patients. Female patients and patients 70 years old or older showed a lower maximal ureteral access sheath insertion force than their counterparts. The rate of grade 2 or greater ureteral injury was lower in the α-blockade group than in controls (p = 0.038). No injury occurred in any case in which ureteral access sheath insertion force did not exceed 600 G.
Preoperative α-blockade and slow sheath placement may reduce maximal ureteral access sheath insertion force. If the force exceeds 600 G, a smaller diameter sheath may be an alternative. Alternatively the procedure can be terminated and followed later by pre-stented retrograde intrarenal surgery.
输尿管导入鞘初次进入时,如果施加过大的扩张力,可能会导致输尿管损伤。本研究旨在探讨术前α受体阻滞剂治疗降低输尿管导入鞘插入力的效果,并确定避免输尿管损伤所需的最大插入力。
本研究为前瞻性随机对照试验,纳入 2015 年 12 月至 2017 年 1 月期间,因肾盂输尿管连接部或肾盂结石,计划行逆行肾内手术的 135 例患者。41 例和 42 例患者分别随机分配至对照组和实验组。实验组患者术前接受α受体阻滞剂治疗,21 例行预置管的患者单独评估。我们开发了一种自制装置来测量最大输尿管导入鞘插入力。
我们的输尿管导入鞘插入力测量装置具有良好的可重复性。更高的插入速度导致更大的最大鞘插入力。在输尿管-膀胱连接处(p = 0.008)和输尿管上段(p = 0.036),α受体阻滞剂组的最大插入力明显低于对照组。α受体阻滞剂组的最大插入力与预置管患者相当。女性和 70 岁以上患者的最大输尿管导入鞘插入力低于同年龄组男性。α受体阻滞剂组的 2 级或更高级别的输尿管损伤发生率低于对照组(p = 0.038)。在最大插入力不超过 600G 的情况下,未发生任何程度的输尿管损伤。
术前α受体阻滞剂治疗和缓慢放置鞘管可能会降低最大输尿管导入鞘插入力。如果插入力超过 600G,可以选择更小直径的鞘管。或者,可以终止该操作,随后进行预置管逆行肾内手术。